Investigating human oral microbiota is now of great interest, being clinically significant for general and oral health. Many research studies have started to focus on the link between oral microbial dysbiosis and Alzheimer's disease. However, little is known about North African populations.
Objective
We aimed to distinguish the dissimilarity in the structure of microbial oral flora between the Alzheimer's disease patients and healthy controls in a Tunisian population.
Methods
We investigated the salivary microbiota using next-generation shotgun sequencing.
Results
The overall structure of the oral microbial community of the Alzheimer's disease patient group was obviously different from the healthy control group. Significantly higher levels of Haemophilus (25.26%) were noticed in the AD group. However, Neisseria (10.17%) showed lower levels compared to the HC group. Considering the disease severity, Selenomonas and Aggregatibacter showed gradually higher levels as the disease progressed. Porphyromonas showed the highest levels in the mild stage of the disease, while Treponema, Selenomonas, and Peptostreptococcus were associated with severe stage. The presence of key taxa, Aggregatibacter and Selenomonas may constitute a dysbiosis signature in individuals with AD.
Conclusions
These findings may be of high relevance for orienting further studies on evaluating the physio-pathological process, confirming the implication of oral microbiota in AD and opening diagnostic and therapeutic avenues.
AragónFZea-SevillaMAMonteroJ, et al.Oral health in Alzheimer’s disease: a multicenter case-control study. Clin Oral Invest2018; 22: 3061–3070.
2.
RosenbergAMangialascheFNganduT, et al.Multidomain interventions to prevent cognitive impairment, Alzheimer's disease, and dementia: from FINGER to world-wide FINGERS. J Prev Alzheimers Dis2020; 7: 29–36.
Andrade-GuerreroJSantiago-BalmasedaAJeronimo-AguilarP, et al.Alzheimer’s disease: an updated overview of its genetics. Int J Mol Sci2023; 24: 3754.
5.
MehtaRIMehtaRI. The vascular-immune hypothesis of Alzheimer’s disease. Biomedicines2023; 11: 408.
6.
WeberCDiltheyAFinzerP. The role of microbiome-host interactions in the development of Alzheimeŕs disease. Front Cell Infect Microbiol2023; 13: 1151021.
7.
MakiKAKazmiNBarbJJ, et al.The oral and gut bacterial microbiomes: similarities, differences, and connections. Biol Res Nurs2021; 23: 7–20.
8.
PiekutTHurłaMBanaszekN, et al.Infectious agents and Alzheimer’s disease. J Integr Neurosci2022; 21: 073.
9.
BorsaLDuboisMSaccoG, et al.Analysis the link between periodontal diseases and Alzheimer’s disease: a systematic review. Int J Environ Res Public Health2021; 18: 9312.
10.
LamontRJKooHHajishengallisG. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol2018; 16: 745–759.
McKhannGMKnopmanDSChertkowH, et al.The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement2011; 7: 263–269.
Ben JemaaSAttia RomdhaneNBahri-MrabetA, et al.An Arabic version of the cognitive subscale of the Alzheimer’s disease assessment scale (ADAS-cog): reliability, validity, and normative data. J Alzheimers Dis2017; 60: 11–21.
15.
FolsteinMFFolsteinSEMcHughPR. Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–198.
16.
BellajTJemaaSBRomdhaneNA, et al.Version Arabe du Mini Mental State Examination (A-MMSE): fidélité, validité et données normatives. Tunisie Med2008; 86: 768–776.
17.
BenoitJSChanWPillerL, et al.Longitudinal sensitivity of Alzheimer’s disease severity staging. Am J Alzheimers Dis Other Demen2020; 35: 1533317520918719.
18.
PapapanouPNSanzMBuduneliN, et al.Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol2018; 89: S173–S182.
19.
KlindworthAPruesseESchweerT, et al.Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucl Acids Res2013; 41: e1.
20.
HartleyJLBowenH. PEG Precipitation for selective removal of small DNA fragments. Focus1996; 18: 27.
21.
BolyenERideoutJRDillonMR, et al.Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol2019; 37: 852–857.
22.
EdgarRC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics2010; 26: 2460–2461.
23.
EdgarRC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods2013; 10: 996–998.
24.
EdgarRC. UNCROSS2: identification of cross-talk in 16S rRNA OTU tables. bioRxiv 2018. DOI: 10.1101/400762[Preprint]. Posted August 27, 2018.
25.
CamachoCCoulourisGAvagyanV, et al.BLAST+: architecture and applications. BMC Bioinformatics2009; 10: 421.
26.
PruesseEQuastCKnittelK, et al.SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucl Acids Res2007; 35: 7188–7196.
27.
PriceMNDehalPSArkinAP. Fasttree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol2009; 26: 1641–1650.
AndersonMJ. A new method for non-parametric multivariate analysis of variance. Austral Ecol2001; 26: 32–46.
31.
BenjaminiYHochbergY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Methodol1995; 57: 289–300.
32.
Bel MokhtarNAsimakisEGaliatsatosI, et al.Development of MetaXplore: an interactive tool for targeted metagenomic analysis. Curr Issues Mol Biol2024; 46: 4803–4814.
33.
DaDZhaoQZhangH, et al.Oral microbiome in older adults with mild cognitive impairment. J Oral Microbiol2023; 15: 2173544.
34.
TuomistoH. A diversity of beta diversities: straightening up a concept gone awry. Part 1. Defining beta diversity as a function of alpha and gamma diversity. Ecography2010; 33: 2–22.
35.
ShannonCE. A mathematical theory of communication. Bell Syst Tech J1948; 27: 379–423.
36.
SimpsonEH. Measurement of diversity. Nature1949; 163: 688–688.
37.
ChaoA. Nonparametric estimation of the number of classes in a population. Scand J Stat1984; 11: 265–270.
38.
SharonIQuijadaNMPasolliE, et al.The core human microbiome: does it exist and how can we find it? A critical review of the concept. Nutrients2022; 14: 2872.
39.
TurnbaughPJLeyREHamadyM, et al.The human microbiome project. Nature2007; 449: 804–810.
40.
SandisonHCallanNGLRaoRV, et al.Observed improvement in cognition during a personalized lifestyle intervention in people with cognitive decline. J Alzheimers Dis2023; 94: 993–1004.
RiesMSastreM. Mechanisms of Aβ clearance and degradation by glial cells. Front Aging Neurosci2016; 8: 160.
43.
ThalDRWalterJSaidoTC, et al.Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease. Acta Neuropathol2015; 129: 167–182.
44.
BeachTGWalkerRMcGeerEG. Patterns of gliosis in Alzheimer’s disease and aging cerebrum. Glia1989; 2: 420–436.
45.
NavarroVSanchez-MejiasEJimenezS, et al.Microglia in Alzheimer’s disease: activated, dysfunctional or degenerative. Front Aging Neurosci2018; 10: 140.
46.
PassamontiLTsvetanovKAJonesPS, et al.Neuroinflammation and functional connectivity in Alzheimer’s disease: interactive influences on cognitive performance. J Neurosci2019; 39: 7218–7226.
47.
FuKChiuMWara-aswapatiN, et al.Oral microbiome and serological analyses on association of Alzheimer’s disease and periodontitis. Oral Dis2023; 29: 3677–3687.
MeyleJChappleI. Molecular aspects of the pathogenesis of periodontitis. Periodontol 20002015; 69: 7–17.
50.
SheppardOColemanM. Alzheimer’s disease: etiology, neuropathology and pathogenesis. In: HuangX (eds) Alzheimer’s disease: drug discovery. Brisbane (AU): Exon Publications, 2020, pp.1–22.
51.
GaoLXuTHuangG, et al.Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell2018; 9: 488–500.
52.
KumarPS. From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease. J Physiol2017; 595: 465–476.
53.
Soria LopezJA. González HM and Léger GC. Alzheimer’s disease. Handb Clin Neurol2019; 167: 231–255.
54.
ShoemarkDKAllenSJ. The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer’s disease. J Alzheimers Dis2015; 43: 725–738.
55.
SødalATTHoveLHDiepMT, et al.Periodontal conditions in a 65-year-old population and prevalence of periodontitis according to three different bone level thresholds. BMC Oral Health2022; 22: 246.
56.
LenartovaMTesinskaBJanatovaT, et al.The oral microbiome in periodontal health. Front Cell Infect Microbiol2021; 11: 629723.
57.
WuY-FLeeW-FSalamancaE, et al.Oral microbiota changes in elderly patients, an indicator of Alzheimer’s disease. Int J Environ Res Public Health2021; 18: 4211.
58.
GuoHLiBYaoH, et al.Profiling the oral microbiomes in patients with Alzheimer’s disease. Oral Dis2023; 29: 1341–1355.
59.
LiuX-XJiaoBLiaoX-X, et al.Analysis of salivary microbiome in patients with Alzheimer’s disease. J Alzheimers Dis2019; 72: 633–640.
60.
KillingsworthJSawmillerDShytleRD. Propionate and Alzheimer’s disease. Front Aging Neurosci2021; 12: 580001.
61.
TrociAPhilippenSRauschP, et al.Disease- and stage-specific alterations of the oral and fecal microbiota in Alzheimer’s disease. PNAS Nexus2023; 3: pgad427.
62.
SuredaADagliaMArgüelles CastillaS, et al.Oral microbiota and Alzheimer’s disease: do all roads lead to Rome?Pharmacol Res2020; 151: 104582.
63.
SanzMBeightonDCurtisMA, et al.Role of microbial biofilms in the maintenance of oral health and in the development of dental caries and periodontal diseases. Consensus report of group 1 of the Joint EFP/ORCA workshop on the boundaries between caries and periodontal disease. J Clin Periodontol2017; 44: S5–S11.
64.
RosarioDBorenJUhlenM, et al.Systems biology approaches to understand the host–microbiome interactions in neurodegenerative diseases. Front Neurosci2020; 14: 716.
65.
IdeMHarrisMStevensA, et al.Periodontitis and cognitive decline in Alzheimer’s disease. PLoS One2016; 11: e0151081.
66.
DominySSLynchCErminiF, et al.Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv2019; 5: eaau3333.
67.
TetzGPinhoMPritzkowS, et al.Bacterial DNA promotes tau aggregation. Sci Rep2020; 10: 2369.
68.
KanagasingamSVon RuhlandCWelburyR, et al.Porphyromonas gingivalis conditioned medium induces amyloidogenic processing of the amyloid-β protein precursor upon in vitro infection of SH-SY5Y cells. J Alzheimers Dis Rep2022; 6: 577–587.
69.
MorikawaTUeharaOPaudelD, et al.Systemic administration of lipopolysaccharide from Porphyromonas gingivalis decreases neprilysin expression in the mouse hippocampus. In Vivo2023; 37: 163–172.
70.
Díaz-ZúñigaJMuñozYMelgar-RodríguezS, et al.Serotype b of Aggregatibacter actinomycetemcomitans triggers pro-inflammatory responses and amyloid beta secretion in hippocampal cells: a novel link between periodontitis and Alzheimeŕs disease?J Oral Microbiol2019; 11: 1586423.
71.
LiKBihanMMethéBA. Analyses of the stability and core taxonomic memberships of the human microbiome. PLoS One2013; 8: e63139.
72.
BouftasM. A systematic review on the feasibility of salivary biomarkers for Alzheimer’s disease. J Prev Alzheimers Dis2021; 8: 84–91.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
